Skip to main navigation

About Us
Products
Patients
Physcians
- Investigator Initiated Study Request
- Medical Education
Payers
News
Careers
Investors
Contact Us

Search

Presentations

News Releases
Events
Presentations

Q3’22 Earnings Call Slides

1013.47 KB

Q2’22 Earnings Call Slides

950.96 KB

Q1’22 Earnings Call Slides

738.34 KB

Q4’21 Earnings Call Slides

718.38 KB

2022 J.P. Morgan Healthcare Conference Presentation

1.23 MB

Q3’21 Earnings Call Slides

994.94 KB

Canaccord Genuity 41st Annual Growth Conference

2.42 MB

Q2’21 Earnings Call Slides

885.28 KB

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix Transcript

66.54 KB

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix Presentation

2.15 MB

Pagination

Current page 1
Page 2
Next page
Last page

Print Page
RSS Feeds
Email Alerts

©2022 Bioventus Inc. All rights reserved.

Terms of Use Copyright & Disclaimer

About Us Products Patients Physicians Payers

News Careers Contact Us Bionet

Bioventus adheres to the AdvaMed Code of Ethics

Bioventus, the Bioventus logo, DUROLANE and EXOGEN are registered trademark of Bioventus LLC.
GELSYN-3 is a trademark of Bioventus LLC.
SUPARTZ FX is a registered trademark of Seikagaku Corp.
All other trade names referenced are the trademarks or registered trademarks of their respective companies.